How your immune system reacts to radiation therapy
Treatments studied
Part of Cancer clinical trials.
This study looks at how your immune system affects how your body reacts to radiation therapy. It involves a blood sample and is for people who have had radiation but no major side effects.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are 18 years of age or older.
- You have received radiation therapy (radiotherapy) before.
- You have not had any serious side effects (grade 2 or higher) from radiation.
- You are willing and able to give a blood sample.
- You can understand and agree to the study procedures.
- You have health insurance (social security).
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study looks at how children's bodies respond to radiation therapy for certain cancers. By analyzing blood samples, researchers hope to learn why some children experience more side effects, which could help personalize future treatments.
This study looks at immune system signals in your blood during and after postoperative radiation therapy for certain head and neck cancers involving the brain or skull base. Researchers want to see whether these “immune markers” relate to treatment response or side effects.
This trial studies how changing your immune system (with earlier treatments) affects cancer by collecting immune cells from your blood using a process called lymphapheresis. It may help researchers find better ways to monitor immune-related responses and side effects.
This study collects immune and tumor-related samples to learn what predicts response to adoptive cell therapy (a treatment using immune cells). If you (or your child) are eligible, you may help researchers understand who benefits and why.
This study looks at how a tumor’s immune system responds when you receive radiotherapy. It involves taking a planned pre-treatment biopsy so researchers can study immune and tumor changes and see if radiotherapy affects them.
This study collects blood and urine samples from patients receiving radiation therapy to understand how the body responds to treatment. It may help researchers improve radiation therapy in the future.
Hear when a new Neoplasms trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.